Industry Research Reports

Home > Reports > Medical Care > Prostate-Specific Antigen (PSA) Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Prostate-Specific Antigen (PSA) Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Care

Published: 2024-01-24

Pages: 108 Pages

Report ld: 2336925

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

Prostate-Specific Antigen (PSA) Test Market Size

M= millions and B=billions

The PSA test measures the level of PSA in a man’s blood. For this test, a blood sample is sent to a laboratory for analysis. The results are usually reported as nanograms of PSA per milliliter (ng/mL) of blood.

The global market for Prostate-Specific Antigen (PSA) Test was estimated to be worth US$ 511 million in 2023 and is forecast to a readjusted size of US$ 628.6 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030
The major players in global PSA Test market include Abbott, Siemens Healthcare, DiaSorin, etc. The top 3 players occupy about 50% shares of the global market. North America and Europe are main markets, they occupy over 80% of the global market. CLIA is the main type, with a share over 70%. Screening is the key application, which holds a share about 80%.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Prostate-Specific Antigen (PSA) Test, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Prostate-Specific Antigen (PSA) Test by region & country, by Type, and by Application.

The Prostate-Specific Antigen (PSA) Test market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostate-Specific Antigen (PSA) Test.

Market Segmentation

Report Metric
Details
Report Title
Prostate-Specific Antigen (PSA) Test - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 628.6 million
CAGR(2024-2030)
2.9%
Market Size Available for Years
2019-2030
Global Prostate-Specific Antigen (PSA) Test Companies Covered
Abbott, Siemens Healthcare, DiaSorin, Roche, Beckman Coulter, PerkinElmer, Tosoh, Ortho Clinical, Fujirebio, Mediwatch (LABORIE), BodiTech
Global Prostate-Specific Antigen (PSA) Test Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate-Specific Antigen (PSA) Test Market, Segment by Type
CLIA

ELISA

Other
Global Prostate-Specific Antigen (PSA) Test Market, Segment by Application
Screening

Post-treatment Monitoring

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Prostate-Specific Antigen (PSA) Test manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Prostate-Specific Antigen (PSA) Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Prostate-Specific Antigen (PSA) Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Prostate-Specific Antigen (PSA) Test Product Introduction
    1.2 Global Prostate-Specific Antigen (PSA) Test Market Size Forecast
    1.3 Prostate-Specific Antigen (PSA) Test Market Trends & Drivers
        1.3.1 Prostate-Specific Antigen (PSA) Test Industry Trends
        1.3.2 Prostate-Specific Antigen (PSA) Test Market Drivers & Opportunity
        1.3.3 Prostate-Specific Antigen (PSA) Test Market Challenges
        1.3.4 Prostate-Specific Antigen (PSA) Test Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Prostate-Specific Antigen (PSA) Test Players Revenue Ranking (2023)
    2.2 Global Prostate-Specific Antigen (PSA) Test Revenue by Company (2019-2024)
    2.3 Key Companies Prostate-Specific Antigen (PSA) Test Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Prostate-Specific Antigen (PSA) Test Product Offered
    2.5 Key Companies Time to Begin Mass Production of Prostate-Specific Antigen (PSA) Test
    2.6 Prostate-Specific Antigen (PSA) Test Market Competitive Analysis
        2.6.1 Prostate-Specific Antigen (PSA) Test Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Prostate-Specific Antigen (PSA) Test Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 CLIA
        3.1.2 ELISA
        3.1.3 Other
    3.2 Global Prostate-Specific Antigen (PSA) Test Sales Value by Type
        3.2.1 Global Prostate-Specific Antigen (PSA) Test Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Prostate-Specific Antigen (PSA) Test Sales Value, by Type (2019-2030)
        3.2.3 Global Prostate-Specific Antigen (PSA) Test Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Screening
        4.1.2 Post-treatment Monitoring
        4.1.3 Other
    4.2 Global Prostate-Specific Antigen (PSA) Test Sales Value by Application
        4.2.1 Global Prostate-Specific Antigen (PSA) Test Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Prostate-Specific Antigen (PSA) Test Sales Value, by Application (2019-2030)
        4.2.3 Global Prostate-Specific Antigen (PSA) Test Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Prostate-Specific Antigen (PSA) Test Sales Value by Region
        5.1.1 Global Prostate-Specific Antigen (PSA) Test Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2019-2024)
        5.1.3 Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2025-2030)
        5.1.4 Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        5.2.2 North America Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        5.3.2 Europe Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        5.4.2 Asia Pacific Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        5.5.2 South America Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        5.6.2 Middle East & Africa Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value
    6.3 United States
        6.3.1 United States Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.3.2 United States Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.4.2 Europe Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.5.2 China Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.6.2 Japan Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.7.2 South Korea Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.8.2 Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Prostate-Specific Antigen (PSA) Test Sales Value, 2019-2030
        6.9.2 India Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Prostate-Specific Antigen (PSA) Test Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Profile
        7.1.2 Abbott Main Business
        7.1.3 Abbott Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.1.4 Abbott Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Recent Developments
    7.2 Siemens Healthcare
        7.2.1 Siemens Healthcare Profile
        7.2.2 Siemens Healthcare Main Business
        7.2.3 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.2.4 Siemens Healthcare Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.2.5 Siemens Healthcare Recent Developments
    7.3 DiaSorin
        7.3.1 DiaSorin Profile
        7.3.2 DiaSorin Main Business
        7.3.3 DiaSorin Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.3.4 DiaSorin Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.3.5 Roche Recent Developments
    7.4 Roche
        7.4.1 Roche Profile
        7.4.2 Roche Main Business
        7.4.3 Roche Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.4.4 Roche Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.4.5 Roche Recent Developments
    7.5 Beckman Coulter
        7.5.1 Beckman Coulter Profile
        7.5.2 Beckman Coulter Main Business
        7.5.3 Beckman Coulter Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.5.4 Beckman Coulter Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.5.5 Beckman Coulter Recent Developments
    7.6 PerkinElmer
        7.6.1 PerkinElmer Profile
        7.6.2 PerkinElmer Main Business
        7.6.3 PerkinElmer Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.6.4 PerkinElmer Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.6.5 PerkinElmer Recent Developments
    7.7 Tosoh
        7.7.1 Tosoh Profile
        7.7.2 Tosoh Main Business
        7.7.3 Tosoh Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.7.4 Tosoh Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.7.5 Tosoh Recent Developments
    7.8 Ortho Clinical
        7.8.1 Ortho Clinical Profile
        7.8.2 Ortho Clinical Main Business
        7.8.3 Ortho Clinical Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.8.4 Ortho Clinical Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.8.5 Ortho Clinical Recent Developments
    7.9 Fujirebio
        7.9.1 Fujirebio Profile
        7.9.2 Fujirebio Main Business
        7.9.3 Fujirebio Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.9.4 Fujirebio Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.9.5 Fujirebio Recent Developments
    7.10 Mediwatch (LABORIE)
        7.10.1 Mediwatch (LABORIE) Profile
        7.10.2 Mediwatch (LABORIE) Main Business
        7.10.3 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.10.4 Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.10.5 Mediwatch (LABORIE) Recent Developments
    7.11 BodiTech
        7.11.1 BodiTech Profile
        7.11.2 BodiTech Main Business
        7.11.3 BodiTech Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
        7.11.4 BodiTech Prostate-Specific Antigen (PSA) Test Revenue (US$ Million) & (2019-2024)
        7.11.5 BodiTech Recent Developments

 8 Industry Chain Analysis
    8.1 Prostate-Specific Antigen (PSA) Test Industrial Chain
    8.2 Prostate-Specific Antigen (PSA) Test Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Prostate-Specific Antigen (PSA) Test Sales Model
        8.5.2 Sales Channel
        8.5.3 Prostate-Specific Antigen (PSA) Test Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Prostate-Specific Antigen (PSA) Test Market Trends
    Table 2. Prostate-Specific Antigen (PSA) Test Market Drivers & Opportunity
    Table 3. Prostate-Specific Antigen (PSA) Test Market Challenges
    Table 4. Prostate-Specific Antigen (PSA) Test Market Restraints
    Table 5. Global Prostate-Specific Antigen (PSA) Test Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Prostate-Specific Antigen (PSA) Test Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Prostate-Specific Antigen (PSA) Test Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Prostate-Specific Antigen (PSA) Test Product Type
    Table 9. Key Companies Time to Begin Mass Production of Prostate-Specific Antigen (PSA) Test
    Table 10. Global Prostate-Specific Antigen (PSA) Test Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate-Specific Antigen (PSA) Test as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Prostate-Specific Antigen (PSA) Test Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Prostate-Specific Antigen (PSA) Test Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Prostate-Specific Antigen (PSA) Test Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Prostate-Specific Antigen (PSA) Test Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Prostate-Specific Antigen (PSA) Test Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Prostate-Specific Antigen (PSA) Test Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Prostate-Specific Antigen (PSA) Test Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Prostate-Specific Antigen (PSA) Test Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Prostate-Specific Antigen (PSA) Test Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Prostate-Specific Antigen (PSA) Test Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Prostate-Specific Antigen (PSA) Test Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2019-2024) & (%)
    Table 27. Global Prostate-Specific Antigen (PSA) Test Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. Siemens Healthcare Basic Information List
    Table 37. Siemens Healthcare Description and Business Overview
    Table 38. Siemens Healthcare Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Siemens Healthcare (2019-2024)
    Table 40. Siemens Healthcare Recent Developments
    Table 41. DiaSorin Basic Information List
    Table 42. DiaSorin Description and Business Overview
    Table 43. DiaSorin Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of DiaSorin (2019-2024)
    Table 45. DiaSorin Recent Developments
    Table 46. Roche Basic Information List
    Table 47. Roche Description and Business Overview
    Table 48. Roche Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Roche (2019-2024)
    Table 50. Roche Recent Developments
    Table 51. Beckman Coulter Basic Information List
    Table 52. Beckman Coulter Description and Business Overview
    Table 53. Beckman Coulter Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Beckman Coulter (2019-2024)
    Table 55. Beckman Coulter Recent Developments
    Table 56. PerkinElmer Basic Information List
    Table 57. PerkinElmer Description and Business Overview
    Table 58. PerkinElmer Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of PerkinElmer (2019-2024)
    Table 60. PerkinElmer Recent Developments
    Table 61. Tosoh Basic Information List
    Table 62. Tosoh Description and Business Overview
    Table 63. Tosoh Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Tosoh (2019-2024)
    Table 65. Tosoh Recent Developments
    Table 66. Ortho Clinical Basic Information List
    Table 67. Ortho Clinical Description and Business Overview
    Table 68. Ortho Clinical Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Ortho Clinical (2019-2024)
    Table 70. Ortho Clinical Recent Developments
    Table 71. Fujirebio Basic Information List
    Table 72. Fujirebio Description and Business Overview
    Table 73. Fujirebio Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Fujirebio (2019-2024)
    Table 75. Fujirebio Recent Developments
    Table 76. Mediwatch (LABORIE) Basic Information List
    Table 77. Mediwatch (LABORIE) Description and Business Overview
    Table 78. Mediwatch (LABORIE) Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of Mediwatch (LABORIE) (2019-2024)
    Table 80. Mediwatch (LABORIE) Recent Developments
    Table 81. BodiTech Basic Information List
    Table 82. BodiTech Description and Business Overview
    Table 83. BodiTech Prostate-Specific Antigen (PSA) Test Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Prostate-Specific Antigen (PSA) Test Business of BodiTech (2019-2024)
    Table 85. BodiTech Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Prostate-Specific Antigen (PSA) Test Downstream Customers
    Table 89. Prostate-Specific Antigen (PSA) Test Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Prostate-Specific Antigen (PSA) Test Product Picture
    Figure 2. Global Prostate-Specific Antigen (PSA) Test Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 4. Prostate-Specific Antigen (PSA) Test Report Years Considered
    Figure 5. Global Prostate-Specific Antigen (PSA) Test Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Prostate-Specific Antigen (PSA) Test Revenue in 2023
    Figure 7. Prostate-Specific Antigen (PSA) Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. CLIA Picture
    Figure 9. ELISA Picture
    Figure 10. Other Picture
    Figure 11. Global Prostate-Specific Antigen (PSA) Test Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Prostate-Specific Antigen (PSA) Test Sales Value Market Share by Type, 2023 & 2030
    Figure 13. Product Picture of Screening
    Figure 14. Product Picture of Post-treatment Monitoring
    Figure 15. Product Picture of Other
    Figure 16. Global Prostate-Specific Antigen (PSA) Test Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Prostate-Specific Antigen (PSA) Test Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Prostate-Specific Antigen (PSA) Test Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Prostate-Specific Antigen (PSA) Test Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Prostate-Specific Antigen (PSA) Test Sales Value (%), (2019-2030)
    Figure 29. United States Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Prostate-Specific Antigen (PSA) Test Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Prostate-Specific Antigen (PSA) Test Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Prostate-Specific Antigen (PSA) Test Sales Value by Application (%), 2023 VS 2030
    Figure 50. Prostate-Specific Antigen (PSA) Test Industrial Chain
    Figure 51. Prostate-Specific Antigen (PSA) Test Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), is a glycoprotein enzyme encoded in humans by the KLK3 gene.

Market Segmentation